- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 13, 2025 | 70.77M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2025 | 70.77M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2025 | 70.67M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 66.38M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 65.35M sh |
| Operating Cash Flow | Q3 2025 · Mar 31, 2025 | −$50.9K |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | −$53.48K |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $8.29K |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $4.18K |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | −$450.52K |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$422.69K |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | −$391.75K |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | −$361.25K |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | −$325.29K |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$314.19K |
| Stockholders Equity | Q3 2025 · Sep 30, 2023 | −$290.8K |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | −$252.01K |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $458.8K |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $365.43K |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $458.8K |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $365.43K |
| Current Assets | Q3 2025 · Mar 31, 2025 | $8.29K |
| Current Assets | Q3 2025 · Jun 30, 2024 | $4.18K |
| Total Assets | Q3 2025 · Mar 31, 2025 | $8.29K |
| Total Assets | Q3 2025 · Jun 30, 2024 | $4.18K |
| Eps Diluted | Q3 2025 · Mar 31, 2025 | $0.00 |
| Eps Diluted | Q3 2025 · Mar 31, 2025 | $0.00 |
| Eps Diluted restated | Q3 2025 · Mar 31, 2024 | $0.00 |
| Eps Diluted restated | Q3 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q3 2025 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q3 2025 · Mar 31, 2025 | $0.00 |
| Eps Basic restated | Q3 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic restated | Q3 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense | Q3 2025 · Mar 31, 2025 | $4.96K |
| Sga Expense | Q3 2025 · Mar 31, 2025 | $16K |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $9.28K |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $63.55K |
| Rd Expense | Q3 2025 · Mar 31, 2025 | $0 |
| Rd Expense | Q3 2025 · Mar 31, 2025 | $0 |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $0 |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $0 |
| Net Income | Q3 2025 · Mar 31, 2025 | −$30.09K |
| Net Income | Q3 2025 · Mar 31, 2025 | −$101.57K |
| Net Income | Q3 2025 · Dec 31, 2024 | −$39.47K |
| Net Income | Q3 2025 · Sep 30, 2024 | −$32K |
| Net Income | Q3 2025 · Mar 31, 2024 | −$53.16K |
| Net Income | Q3 2025 · Mar 31, 2024 | −$152.6K |
| Net Income | Q3 2025 · Dec 31, 2023 | −$24.52K |
| Net Income | Q3 2025 · Sep 30, 2023 | −$74.92K |
| Operating Income | Q3 2025 · Mar 31, 2025 | −$11.64M |